Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism MmpL3 inhibitors(Mycobacterium tuberculosis mycolic acid transporter inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H20ClNO2S |
InChIKeyRSLSMMBCSGWZOC-UHFFFAOYSA-N |
CAS Registry877650-26-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Tuberculosis | Preclinical | US | 01 Jul 2018 |